Oct 18, 2023 08:02AM
Oct 18, 2023 08:00AM
Sep 28, 2023 08:01AM
Sep 28, 2023 08:00AM
Sep 7, 2023 08:00AM
Aug 23, 2023 08:01AM
Aug 23, 2023 08:00AM Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Aug 16, 2023 08:00AM
Jun 30, 2023 08:01AM
Jun 30, 2023 08:00AM
May 12, 2023 08:32AM
Apr 24, 2023 04:30PM
Apr 24, 2023 04:30PM
Feb 23, 2023 08:00AM Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
Feb 23, 2023 08:00AM
Jan 3, 2023 07:40AM
Nov 8, 2022 04:09PM
Nov 8, 2022 04:09PM
Aug 22, 2022 08:04AM
Aug 22, 2022 08:00AM
Aug 22, 2022 08:00AM Baudax Bio receives notice of allowance for U.S. Patent Application covering use of ANJESO® for the treatment of moderate to severe pain
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
May 4, 2022 05:00PM
May 4, 2022 05:00PM
Mar 16, 2022 08:00AM
Mar 16, 2022 08:00AM
Mar 2, 2022 07:02AM Baudax Bio (BXRX) Granted Seventh Orange Book Listable Patent for ANJESO
Mar 2, 2022 07:00AM
Mar 2, 2022 07:00AM
Jan 4, 2022 10:38AM
Nov 11, 2021 07:04AM
Nov 11, 2021 07:00AM
Nov 11, 2021 07:00AM
Nov 4, 2021 07:00AM Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
Nov 4, 2021 07:00AM
Aug 5, 2021 07:00AM
Aug 5, 2021 07:00AM
May 17, 2021 07:11AM
May 17, 2021 07:00AM
May 17, 2021 07:00AM
May 5, 2021 07:00AM Baudax Bio Reports First Quarter 2021 Financial Results
May 5, 2021 07:00AM
Apr 26, 2021 07:09AM
Apr 26, 2021 07:00AM
Apr 26, 2021 07:00AM
Apr 8, 2021 04:05PM
Apr 8, 2021 04:05PM
Apr 1, 2021 07:00AM Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr 1, 2021 07:00AM

322,086 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All